Literature DB >> 22296504

Transcription of promoter from the human APRIL gene regulated by Sp1 and NF-kB.

J Xu1, W F Ding, K K Shao, X D Wang, G H Wang, H Q Li, H M Wang.   

Abstract

A proliferation-inducing ligand (APRIL) which stimulates the cell proliferation is abundantly expressed in colorectal cancer (CRC) tumors. In this report, the promoter region of the APRIL gene was determined and the major transcription factor was investigated for the first time. Deletion analysis of 5'-flanking region of the human APRIL gene and transient transfection revealed that a 538 bp region (from -1539 to -1001) was essential for promoter activation of the APRIL gene. The data from electrophoretic mobility shift assays (EMSA) indicated that the 538 bp promoter region was responsive to the specificity protein 1 (Sp1) and nuclear factor kappa B (NF-kB). Overexpression of Sp1 or NF-kB increased the activity of the APRIL promoter. Mithramycin A (inhibitor of Sp1) and Bay11-7082 (inhibitor of NF-kB) exhibited an inhibitory activity to APRIL promoter. Our results will benefit to the APRIL gene regulation investigation and contribute to discover new drug target for the APRIL gene therapy of CRC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22296504     DOI: 10.4149/neo_2012_044

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  7 in total

1.  APRIL depletion induces cell cycle arrest and apoptosis through blocking TGF-β1/ERK signaling pathway in human colorectal cancer cells.

Authors:  Feng Wang; Lin Chen; Hongbin Ni; Guihua Wang; Weifeng Ding; Hui Cong; Shaoqing Ju; Shumei Yang; Huimin Wang
Journal:  Mol Cell Biochem       Date:  2013-07-20       Impact factor: 3.396

2.  Contribution of transcription factor, SP1, to the promotion of HB-EGF expression in defense mechanism against the treatment of irinotecan in ovarian clear cell carcinoma.

Authors:  Kohei Miyata; Fusanori Yotsumoto; Sung Ouk Nam; Takashi Odawara; Sadao Manabe; Toyokazu Ishikawa; Hiroaki Itamochi; Junzo Kigawa; Shuji Takada; Hiroshi Asahara; Masahide Kuroki; Shingo Miyamoto
Journal:  Cancer Med       Date:  2014-07-24       Impact factor: 4.452

3.  An LGG-derived protein promotes IgA production through upregulation of APRIL expression in intestinal epithelial cells.

Authors:  Y Wang; L Liu; D J Moore; X Shen; R M Peek; S A Acra; H Li; X Ren; D B Polk; F Yan
Journal:  Mucosal Immunol       Date:  2016-06-29       Impact factor: 7.313

4.  Serum Levels of APRIL Increase in Patients with Glioma, Meningioma and Schwannoma

Authors:  Hamed Fouladseresht; Seyyed Mohyeddin Ziaee; Nasrollah Erfani; Mehrnoosh Doroudchi
Journal:  Asian Pac J Cancer Prev       Date:  2019-03-26

5.  Gene cascade analysis in human granulosa tumor cells (KGN) following exposure to high levels of free fatty acids and insulin.

Authors:  Patricia G Tremblay; Chloé Fortin; Marc-André Sirard
Journal:  J Ovarian Res       Date:  2021-12-20       Impact factor: 4.234

6.  Tumor necrosis factor superfamily member APRIL contributes to fibrotic scar formation after spinal cord injury.

Authors:  Lucy H Funk; Amber R Hackett; Mary Bartlett Bunge; Jae K Lee
Journal:  J Neuroinflammation       Date:  2016-04-20       Impact factor: 8.322

7.  LT-K63 Enhances B Cell Activation and Survival Factors in Neonatal Mice That Translates Into Long-Lived Humoral Immunity.

Authors:  Audur Anna Aradottir Pind; Jenny Lorena Molina Estupiñan; Gudbjorg Julia Magnusdottir; Giuseppe Del Giudice; Ingileif Jonsdottir; Stefania P Bjarnarson
Journal:  Front Immunol       Date:  2020-10-23       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.